Supplements for PMDD: Evidence, Doses and What to Skip
If your mood drops in the week before your period and lifts a few days after it starts, you have probably searched for supplements for PMDD. Most pages sell a stack, not evidence. This guide does the opposite. It starts with whether you meet the PMDD threshold, covers first-line care, then grades each nutrient by the population tested. Much of that evidence comes from premenstrual syndrome (PMS), not PMDD, and that distinction changes how much weight each finding deserves.
Do You Even Meet the PMDD Threshold
PMDD is a diagnosis, not a bad week. The DSM-5 timing pattern is specific. Symptoms appear in the final week before your period, improve within a few days of bleeding, and are minimal or absent in the week after (ACOG).
You cannot confirm that from memory. The standard is daily symptom tracking across at least two cycles. Rate mood, sleep, appetite and physical symptoms daily, then look at the shape of the month.
A 2024 meta-analysis of 44 studies and 50,659 participants found pooled prevalence of 3.2 percent for confirmed PMDD and 7.7 percent for provisional cases. In community samples, confirmed cases fell to 1.6 percent (Reilly et al.).
The same symptoms can come from thyroid disease, anemia, depression or perimenopause. Tracking tells you which one you are dealing with.
PMDD vs PMS and What the Difference Actually Is
PMS is the broad category. Most people who menstruate report at least one luteal-phase symptom. PMDD is the severe end, with mood symptoms that disrupt work, relationships and daily function.
Common PMDD symptoms include:
- Marked irritability, anger or conflict
- Depressed mood or hopelessness
- Anxiety or tension
- Loss of interest in things you enjoy
- Trouble concentrating
- Fatigue, sleep or appetite changes
- Breast tenderness, bloating or headache
PMDD needs at least one mood symptom plus enough total symptoms to cause impairment. If cramping is your main complaint and your mood is steady, a guide to period cramps and supplements fits better than this one.
First-Line PMDD Treatment Comes Before Supplements
ACOG's 2023 clinical practice guideline describes premenstrual care as multimodal. The main recommended options are SSRIs (first-line pharmacologic), hormonal options such as combined oral contraceptives, and cognitive behavioral therapy (CBT).
Supplements are adjuncts, not replacements for first-line care. If your symptoms meet the PMDD threshold, discuss SSRIs, hormonal options and CBT with a clinician first. A supplement can then support what remains.
SSRIs are first-line for a reason, and CBT teaches skills a capsule cannot. If anxiety is loudest, our overview of supplements for anxiety can sit beside that conversation, not in place of it.
What the Evidence Says About Supplements for PMDD
Here is the short version. Almost every trial below enrolled people with PMS, not PMDD. Only a few small trials enrolled confirmed PMDD. Calcium has the strongest body of evidence, chasteberry has the longest track record, and evening primrose oil does not hold up.
| Nutrient | Dose used in trials | What was studied | Sample size | Verdict |
|---|---|---|---|---|
| Calcium | 1,200 mg elemental daily, 3 cycles | PMS, four symptom factors | 466 analyzed | Best-supported option, within-arm response |
| Vitamin B6 | Up to 100 mg daily | PMS, 9 trials pooled | 940 patients | Modest benefit, dose ceiling matters |
| Magnesium | 200 mg as magnesium oxide | PMS, fluid retention, crossover | 38 women | Possible benefit after two cycles |
| Chasteberry | 20 to 40 mg standardized extract daily | PMS meta-analysis plus one PMDD trial | 17 RCTs (14 pooled), plus n=41 | Reasonable option, evidence uneven |
| Saffron | 30 mg daily (15 mg twice daily) | PMS and PMDD trials | 120 in the PMDD trial | Promising, still preliminary |
| Evening primrose oil | Varied by trial | PMS, 7 trials | 7 trials reviewed | Skip, no better than placebo |
Calcium for PMDD
Calcium has the largest and most consistent trial behind it. In a trial of 466 women with PMS, 1,200 mg of elemental calcium daily for three cycles produced a 48 percent reduction in symptom scores by cycle three. The placebo group improved by 30 percent. All four symptom factors improved: mood, water retention, food cravings and pain.
The 48 percent and 30 percent are within-arm reductions from baseline, not a 48-point gap between groups. Both groups improved, and the gap between them is what matters. The trial enrolled PMS, so it supports calcium for premenstrual symptoms in general, not as a treatment for PMDD.
Calcium is still a reasonable first supplement. Food counts toward the total, so split doses across the day. People with a history of kidney stones should ask a clinician first.
Vitamin B6 for PMDD
Vitamin B6 has a long history in premenstrual research and a clear ceiling. A review of 9 trials and 940 patients found an overall odds ratio of 2.32 for improvement with B6 versus placebo. For depressive symptoms, the odds ratio was 1.69. Doses went up to 100 mg per day.
Those numbers sound strong until you weigh the trial quality. The review authors were cautious, and later guidelines have not made B6 first-line. B6 may help with mood and irritability, but the effect is modest and the dose ceiling is real.
Chronic doses above 100 mg daily can cause peripheral neuropathy, which starts as numbness or tingling in the hands and feet. Stay at or below 100 mg unless a clinician says otherwise.
Magnesium for PMDD
Magnesium has smaller trials and narrower findings. In a crossover study of 38 women with PMS, 200 mg of magnesium as magnesium oxide helped fluid retention, but only in the second cycle (p=0.009). The first cycle showed no such effect.
A separate trial of 44 women combined 200 mg of magnesium with 50 mg of vitamin B6 for one month. The pair produced a modest improvement in anxiety-related symptoms (p=0.040). That is a small study with a small effect, and it tested the combination, not magnesium alone.
Magnesium is generally well tolerated. Loose stools are common, and glycinate or citrate tends to be gentler than oxide. Anyone with kidney impairment should check with a clinician first.
Chasteberry for PMDD
Chasteberry (Vitex agnus-castus) is the supplement most people mean by natural remedies for PMDD. Standardized extracts are usually dosed at 20 to 40 mg daily, and trials mostly used branded extracts like Ze 440 and BNO 1095.
The pooled evidence looks strong. A 2017 meta-analysis of 17 randomized trials, 14 pooled, found a Hedges g of -1.21 for symptom improvement. It carries 91 percent heterogeneity and likely publication bias.
A 2019 meta-analysis of 3 double-blind trials and 520 women found a risk ratio of 2.57 for symptom remission with two standardized extracts. A 2017 review of 8 trials found positive results and good tolerability.
The PMDD data comes from one small trial. In a head-to-head study of 41 women with PMDD, 68.4 percent of the fluoxetine group responded and 57.9 percent of the chasteberry group responded. The difference was not statistically significant. Fluoxetine was better for mood, and chasteberry was better for physical symptoms. Chasteberry may interact with hormonal contraception, so ask a clinician before combining them.
Saffron for PMDD
Saffron is the newest option and has a dedicated PMDD trial. A 2008 randomized trial found that 30 mg daily, taken as 15 mg twice daily for two cycles, improved Daily Symptom Report and Hamilton Depression Rating Scale scores in PMS.
The 2020 trial is more relevant. It enrolled 120 women and compared fluoxetine 20 mg twice daily, saffron 15 mg twice daily, and placebo across two luteal phases. Saffron beat placebo on the Daily Record of Severity of Problems (DRSP), and fluoxetine caused more adverse effects.
Saffron is promising for PMDD symptoms, but the evidence is still preliminary. Saffron can interact with blood thinners and should not be combined with SSRIs without medical advice.
What to Skip and What Not to Stack
Evening primrose oil (EPO) is the most commonly recommended supplement that does not hold up. A 1996 review of 7 trials found the two best-controlled studies showed no benefit over placebo. The authors concluded EPO was of little value for PMS.
St John's wort, 5-HTP and SAM-e deserve a harder stop. Each can raise serotonin, and combining any of them with an SSRI raises the risk of serotonin syndrome, which can cause agitation, fever, rapid heart rate and confusion. Do not stack serotonergic supplements with an SSRI or with each other without a clinician's guidance.
St John's wort has no controlled PMDD trial showing a mood benefit and interacts with many drugs, including hormonal contraceptives. 5-HTP and SAM-e have limited premenstrual data. None belongs in a self-assembled stack.
What to Test Before You Buy Anything
Testing costs less than a shelf of supplements and rules out conditions that look like PMDD. Ask for ferritin and a complete blood count first. Low iron can cause fatigue, low mood and poor concentration that can be mistaken for premenstrual symptoms. Our guide to iron supplements explains ferritin numbers.
A thyroid panel (TSH) is next, since thyroid disease can mimic PMS and depression. Check vitamin D, B12 and folate too, especially on a plant-based diet. Our guides to B12 deficiency symptoms and vitamin D3 and K2 cover the signs.
A 2019 review of 28 papers found low luteal calcium and vitamin D were associated with worse premenstrual symptoms. That is an association, not proof that raising either one fixes the problem, but it is a reason to test rather than guess.
Also screen for depression, perimenopause and thyroid disease with a clinician.
Safety and Who Should Not Take These
PMDD carries a safety risk most supplement pages ignore. A 2021 meta-analysis of 6 studies and 8,532 participants found an odds ratio of 2.34 for suicidal ideation and 2.13 for suicide attempt in people with PMDD. If you are having thoughts of harming yourself, call or text 988 in the US right now. The line is free and open 24 hours a day.
Pregnancy and breastfeeding change the calculation. Chasteberry, saffron and high-dose B6 need a clinician's approval first, and calcium and magnesium upper limits still apply.
Other cautions:
- Chasteberry may interact with hormonal contraception.
- High-dose calcium may raise kidney stone risk in people with a history of stones.
- Magnesium should be used cautiously in kidney impairment.
- St John's wort, 5-HTP and SAM-e can cause serotonin syndrome with SSRIs.
- Vitamin B6 above 100 mg daily, long term, can damage nerves.
A Three-Step Sequence That Actually Makes Sense
Most readers need an order, not five bottles.
Step one: build the foundation. Track symptoms daily for two cycles, protect sleep, eat regular meals with protein, and move most days. Poor sleep can amplify symptoms, and our guide to supplements for sleep can help if that is the bottleneck.
Step two: add one supplement at a time. Pick the nutrient that best matches your main symptom, take a consistent dose, and give it two to three cycles. Calcium suits mood and physical symptoms. Chasteberry suits physical symptoms and has the only PMDD head-to-head data. Saffron is a reasonable second choice.
Step three: reassess with your tracking data. If nothing changed after two to three cycles, stop and try another lever. If something helped, keep the lowest effective dose.
What We Recommend
The products below match the evidence covered in this guide: a calcium option, a magnesium option and a standardized chasteberry extract. Each one is an adjunct to first-line care, not a replacement for it. If your symptoms meet the PMDD threshold, keep the SSRI, hormonal and CBT conversation with a clinician first.
Integrative Therapeutics, Magnesium Glycinate Plus 120 Tablets
The magnesium evidence above comes from 200 mg of magnesium oxide; this product is a glycinate option with 2 tablets supplying 220 mg, so the form differs from the one studied.
$29.25
Integrative Therapeutics, Vitex Extract 60 Veg Capsules
The chasteberry trials used standardized Vitex extracts and this is the same herb standardized to 0.5 percent agnusides at 1 capsule twice daily, though it is not one of the branded extracts that were tested.
$27.50
DaVinci Labs, Cal-MAG Citrate Powder 30 Servings
One scoop supplies 600 mg of calcium citrate and 300 mg of magnesium, so pair one scoop with calcium-rich food; if you also take a standalone magnesium product, count both, since combined supplemental magnesium can exceed the daily upper limit.
$22.90
Frequently Asked Questions
What is the best supplement for PMDD?
There is no single best supplement. Calcium has the strongest trial evidence, though it was studied in PMS. Chasteberry has the only head-to-head trial in confirmed PMDD, where it matched fluoxetine overall but lagged for mood.
Can I take PMDD supplements with an SSRI?
Some are, some are not. Calcium, magnesium and B6 are generally compatible at usual doses. St John's wort, 5-HTP and SAM-e should not be combined with an SSRI because of serotonin syndrome risk. Chasteberry and saffron need a clinician's sign-off.
Is chasteberry safe with hormonal birth control?
Not enough is known to call it safe. Chasteberry may affect hormone signaling and has a theoretical interaction with combined oral contraceptives. Ask your prescriber before combining them, especially if you rely on the pill.
Do I need a diagnosis before trying supplements?
Yes, or at least two cycles of daily tracking. PMDD has a specific timing pattern, and other conditions can produce similar symptoms. Tracking tells you whether you are treating the right thing.
References
- Thys-Jacobs S, et al. Calcium carbonate and the premenstrual syndrome: effects on premenstrual and menstrual symptoms. Am J Obstet Gynecol. 1998. https://pubmed.ncbi.nlm.nih.gov/9731851/
- Wyatt KM, et al. Efficacy of vitamin B-6 in the treatment of premenstrual syndrome: systematic review. BMJ. 1999. https://pubmed.ncbi.nlm.nih.gov/10334745/
- Walker AF, et al. Magnesium supplementation alleviates premenstrual symptoms of fluid retention. J Womens Health. 1998. https://pubmed.ncbi.nlm.nih.gov/9861593/
- De Souza MC, et al. A synergistic effect of a daily supplement for 1 month of 200 mg magnesium plus 50 mg vitamin B6 for the relief of anxiety-related premenstrual symptoms. J Womens Health Gend Based Med. 2000. https://pubmed.ncbi.nlm.nih.gov/10746516/
- Verkaik S, et al. The treatment of premenstrual syndrome with preparations of Vitex agnus castus: a systematic review and meta-analysis. Am J Obstet Gynecol. 2017. https://pubmed.ncbi.nlm.nih.gov/28237870/
- Csupor D, et al. Vitex agnus-castus in premenstrual syndrome: a meta-analysis of double-blind randomised controlled trials. Complement Ther Med. 2019. https://pubmed.ncbi.nlm.nih.gov/31780016/
- Cerqueira RO, et al. Vitex agnus castus for premenstrual syndrome and premenstrual dysphoric disorder: a systematic review. Arch Womens Ment Health. 2017. https://pubmed.ncbi.nlm.nih.gov/29063202/
- Atmaca M, et al. Fluoxetine versus Vitex agnus castus extract in the treatment of premenstrual dysphoric disorder. Hum Psychopharmacol. 2003. https://pubmed.ncbi.nlm.nih.gov/12672170/
- Agha-Hosseini M, et al. Crocus sativus L. (saffron) in the treatment of premenstrual syndrome: a double-blind, randomised and placebo-controlled trial. BJOG. 2008. https://pubmed.ncbi.nlm.nih.gov/18271889/
- Rajabi F, et al. Saffron for the management of premenstrual dysphoric disorder: a randomized controlled trial. Adv Biomed Res. 2020. https://pubmed.ncbi.nlm.nih.gov/33457343/
- Budeiri D, et al. Is evening primrose oil of value in the treatment of premenstrual syndrome? Control Clin Trials. 1996. https://pubmed.ncbi.nlm.nih.gov/8721802/
- Abdi F, et al. A systematic review of the role of vitamin D and calcium in premenstrual syndrome. Obstet Gynecol Sci. 2019. https://pubmed.ncbi.nlm.nih.gov/30918875/
- ACOG Clinical Practice Guideline No. 7. Management of premenstrual disorders. Obstet Gynecol. 2023. https://pubmed.ncbi.nlm.nih.gov/37973069/
- Premenstrual Syndrome and Premenstrual Dysphoric Disorder. Am Fam Physician. 2016. https://pubmed.ncbi.nlm.nih.gov/27479626/
- Reilly TJ, et al. The prevalence of premenstrual dysphoric disorder: systematic review and meta-analysis. J Affect Disord. 2024. https://pubmed.ncbi.nlm.nih.gov/38199397/
- Yan H, et al. Suicidality in patients with premenstrual dysphoric disorder: a systematic review and meta-analysis. J Affect Disord. 2021. https://pubmed.ncbi.nlm.nih.gov/34488087/
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
